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Materials and methods
All solvents and reagents were obtained from commercial sources and used as received.
Column chromatography was performed on Selecto™ silica gel (Fisher).
H and 13
C NMR spectra were recorded on a Brucker DPX-500 spectrometer. Mass-spectra were obtained on a Waters LC-MS workstation, using 1% TFA in MeCN/ 1% TFA in water as mobile phase.
Analytical and Radio HPLC was performed using a Schimadzu Epic C-18 5 μm column (4.6x250 mm) with two-solvent gradient elution (0.1% TFA in water; 0.1% TFA in acetonitrile).
Semi-preparative HPLC was performed using a Waters XBridge Prep BEH130 C18 5 μm column (10x250 mm) and the same solvent system. Compound 1 was obtained according to the literature procedure. [1] To the solution of 1 (20 mg, 0.058 mmol) in acetonitrile (2 ml), K 2 CO 3 (14 mg, 0.1 mmol) was added followed by propargyl bromide (12 mg of 80% solution in toluene, 0.1 mmol).
Synthesis and radiolabeling.

tert-butyl
Mixture was stirred overnight at room temperature. Solvent was evaporated, and the residue purified on short silica gel column (1 x 3 cm, CH 2 Cl 2 :MeOH 5:1). Solvent was evaporated and the residual oil was dried in vacuum. Yield: 19 mg, 86%. To the solution of tri-tert-butyl 2,2',2''-(1,4,7,10-tetraazacyclododecane-1,4,7-triyl)triacetate (20 mg, 0.039 mmol) in acetonitrile (2 ml), K 2 CO 3 (14 mg, 0.1 mmol) was added followed by propargyl bromide (12 mg of 80% solution in toluene, 0.1 mmol). Mixture was stirred overnight at room temperature. Solvent was evaporated, and the residue purified on short silica gel column (1 x 3 cm, CH 2 The starting material (10 mg, 0.013 mmol) was dissolved in 1 ml of DMSO. Propargyl amine (5.5 mg, 0.1 mmol) was added and the reaction was left overnight at RT. Water (10 ml) was added to the reaction mixture and the resulting solution was applied onto C-18 cartridge Bromide derivative was dissolved in DMF (6 ml) and NaN 3 (1.35 g, 20 mmol) was added.
The mixture was vigorously stirred overnight. The solution was filtered, and the precipitate was washed with DMF (4 ml). Combined DMF solution was diluted with ether (50 ml), the precipitate was collected by centrifugation and washed with ether again. It was dissolved in TFA (3ml), TFA was evaporated in vacuum. The residue was taken up into acetonitrile (20 ml), acetonitrile solution was filtered through a cotton clot, evaporated in vacuum and the residue was redissolved in acetonitrile again (it is important to eliminate even traces of TFA, for it forms an insoluble salt with dicyclohexylamine). Dicyclohexylamine (1 ml) was added to the solution N solution in water) was added. Black precipitate appeared immediately, the mixture was centrifuged, supernatant was collected and the precipitate was washed with 1 ml of water via suspension/centrifugation. All washings were combined, diluted to 10 ml with water and applied on C-18 cartridge (primed with ethanol [10 ml], then and water [10 ml]). The cartridge was washed with additional 10 ml of water and the product was eluted with acetonitrile (10 ml). Acetonitrile was evaporated in vacuum. To obtain analytically pure material HPLC purification can be performed at this point, otherwise the peptide was deprotected without additional purification. Deprotection was performed by treating the residue with 3 ml of the cleavage cocktail (2.5 iPr 3 SiH, 1% of water and 1% of HSCH 2 CH 2 SH in trifluoroacetic acid) for 7 h.
TFA was evaporated in vacuum and the product was isolated by semi-preparative HPLC, 5 ml of the solution ca. 0.2 mg/ml were collected. 
DOTA-QWAVGHLM (7)
The procedure described for CB-TE2A-QWAVGHLM (6) was employed. 5 ml of the solution ca. 0.2 mg/ml were collected. 
Density Functional Theory (DFT) Calculations
All calculations were conducted using density functional theory (DFT) as implemented in the Gaussian03 suite of ab initio quantum chemistry programs. [2] Geometry optimizations and vibrational frequency calculations were performed by using the unrestricted B3LYP exchange and correlation functionals and the double-ζ 6-31+G(d,p) basis set for all atoms. [3] [4] [5] [6] Normal selfconsistent field (SCF) and geometry convergence criteria were employed and the geometry of complex 1 was optimized in the gas phase without the use of symmetry constraints. Harmonic frequency analysis based on analytical second derivates was used to characterize the optimized geometries as local minima. 472  464  456  448  440  432  424  416  408  400  392  384  376  368  360  352  344  336  328  320  312 1000  980  960  940  920  900  880  860  840  820  800  780  760  740  720  700  680  660  640  620 1700  1650  1600  1550  1500  1450  1400  1350  1300  1250  1200  1150  1100  1050  1000  950  900  850  800  750 M+2H   +   M+H   +   2M+3H   +   1700  1650  1600  1550  1500  1450  1400  1350  1300  1250  1200  1150  1100  1050  1000  950  900  850  800  750 
CB-TE2A-GRP (6): ESI+
DOTA-GRP (7): ESI+
